Legal highs and lows

dc.contributor.author	Guirguis, Amira
dc.date.accessioned	2017-08-03T14:21:20Z
dc.date.available	2017-08-03T14:21:20Z
dc.date.issued	2016-02
dc.identifier.citation	Guirguis , A 2016 , ' Legal highs and lows ' , The Analytical Scientist , no. 17 , pp. 34-40 .
dc.identifier.other	PURE: 12214755
dc.identifier.other	PURE UUID: 62d0ad83-8691-41ab-b6c6-73365f834823
dc.identifier.other	ORCID: /0000-0001-8255-0660/work/62748678
dc.identifier.uri	http://hdl.handle.net/2299/19117
dc.description.abstract	As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we are faced with significant – and growing – social and analytical challenges. Here, I offer an overview of a quietly unraveling crisis.	en
dc.language.iso	eng
dc.relation.ispartof	The Analytical Scientist
dc.title	Legal highs and lows	en
dc.contributor.institution	School of Life and Medical Sciences
dc.contributor.institution	Department of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institution	Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.description.status	Non peer reviewed
rioxxterms.version	AM
rioxxterms.type	Journal Article/Review
herts.preservation.rarelyaccessed	true